Old Web
English
Sign In
Acemap
>
authorDetail
>
Joanne Betts
Joanne Betts
AstraZeneca
Medicine
Pharmacology
Tolerability
Pharmacokinetics
Asthma
4
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Characterisation of pharmacokinetics, safety and tolerability in a first-in-human study for AZD8154, a novel inhaled selective PI3Kγδ dual inhibitor targeting airway inflammatory disease.
2021
British Journal of Clinical Pharmacology
Muhammad Waqas Sadiq
Sara Asimus
Maria G. Belvisi
Wayne Brailsford
Rebecca Fransson
Rainard Fuhr
Anette Hagberg
Mahdi Hashemi
Tina Jellesmark Jensen
Julia Jonsson
Christina Keen
Thomas Körnicke
Cecilia Kristensson
Jukka Mäenpää
Sofia Necander
Szilard Nemes
Joanne Betts
Show All
Source
Cite
Save
Citations (0)
Complexity of design in early phase respiratory clinical trials; evaluating impact of primary endpoints and sponsor size.
2021
Contemporary clinical trials communications
Nicolas Marco-Ariño
Alexandra Jauhiainen
Joanne Betts
Carla A. Da Silva
Show All
Source
Cite
Save
Citations (0)
Safety, tolerability and pharmacokinetics (PK) of AZD8154 (a selective PI3K?d inhibitor) after single ascending inhaled doses in healthy volunteers
2019
European Respiratory Journal
Muhammad Waqas Sadiq
Sara Asimus
Cecilia Kristensson
Anette Hagberg
Jukka Mäenpää
Barbara Valastro
Rainard Fuhr
Thomas Koernicke
Christina Keen
Wayne Brailsford
Joanne Betts
Show All
Source
Cite
Save
Citations (0)
P138 Urinary leukotriene E4 (uLTE4) pharmacodynamic biomarker for early decision making in the AZD9898 adaptive phase i study
2018
Thorax
Joanne Betts
Bengt Larsson
A. Jauhiainen
Tove Hegelund Myrbäck
J. Leander
A Berton
Pernilla Glader
A. Aurell Holmberg
Z Santisteban
J Franzén
M. Albayaty
Christina Keen
Cecilia Kristensson
Show All
Source
Cite
Save
Citations (1)
1